retatrutide trial status produces up to 30.3% weight loss in Phase 3 The retatrutide drug is manufactured

For so many people, years of frustration can make sustainable weight loss feel out of reach

This review highlights the advancements in the field of organoid technology from the perspectives of disease modeling and personalized therapy.

The FDA also raised concerns about contamination, incorrect dosages, unapproved or harmful ingredients, and counterfeit components in compounded GLP-1s

A Renewed Look at an Old Controversy Ever since GLP-1 receptor agonists (GLP-1 RAs) entered clinical practice for diabetes and obesity, their metabolic benefits have been undeniable

This is a citation of Dr

Protein is key to weight loss, especially on GLP-1 meds like semaglutide and tirzepatide